Back to Markets
KYKyverna Therapeutics Inc

Kyverna Therapeutics Inc

KYTX
Health CareBiotechnology: Biological Products (No Diagnostic Substances)

$8.52

-0.130000 (-1.50%)

As of 05/29/26 EDT · USD

Compare
Low: $2.52Current: $8.52High: $13.67

Key Statistics

Open

$8.60

Day High

$8.70

Day Low

$8.33

Prev. Close

$8.65

VolumeShares traded today.

601.62K

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$517.98M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-2.60

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$13.67

52W LowLowest price over the past 52 weeks.

$2.52

50D MAAverage closing price over the last 50 trading days.

$9.04

200D MAAverage closing price over the last 200 trading days.

$7.56

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-4.3%

1M

+1.4%

6M

+15.3%

YTD

-2.9%

1Y

+234.1%

About

Intellia Therapeutics, Inc. is an American clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which the company's proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Intellia's ex vivo programs use CRISPR to create the therapy by using engineered human cells to treat cancer and autoimmune diseases.

Company Facts

SectorHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade KYTX

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.